journal
MENU ▼
Read by QxMD icon Read
search

Journal of Oncology Practice

journal
https://www.readbyqxmd.com/read/29791246/curative-stereotactic-ablative-radiotherapy-for-a-locally-advanced-basal-cell-carcinoma-in-an-elderly-patient
#1
Ines B Menjak, Teresa M Petrella, Justin W Lee
No abstract text is available yet for this article.
May 23, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29787333/investigator-disclosure-and-advanced-cancer-patient-understanding-of-informed-consent-and-prognosis-in-phase-i-clinical-trials
#2
Fay J Hlubocky, Nancy E Kass, Debra Roter, Susan Larson, Kristen E Wroblewski, Jeremy Sugarman, Christopher K Daugherty
PURPOSE: Advanced cancer patients (ACPs) who participate in phase I clinical trials often report a less-than-ideal understanding of the required elements of informed consent (IC) and unrealistic expectations for anticancer benefit and prognosis. We examined phase I clinical trial enrollment discussions and their associations with subsequent ACP understanding. METHODS: Clinical encounters about enrollment in phase I trials between 101 ACPs and 29 oncologists (principal investigators [PIs] and fellows) at three US academic medical institutions were recorded...
May 22, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29787332/comparison-of-nine-tools-for-screening-drug-drug-interactions-of-oral-oncolytics
#3
Lauren A Marcath, Jingyue Xi, Emily K Hoylman, Kelley M Kidwell, Shawna L Kraft, Daniel L Hertz
PURPOSE: Patients with cancer are an especially vulnerable population to potential drug-drug interactions (DDIs). This makes it important to adequately screen them for DDIs. The objective of this study was to compare the abilities of nine DDI screening tools to detect clinically relevant interactions with oral oncolytics. METHODS: Subscription-based tools (ie, PEPID, Micromedex, Lexicomp, Facts & Comparisons) and free tools (ie, Epocrates Free, Medscape, Drugs...
May 22, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29768110/fertility-preservation-in-patients-with-cancer-asco-clinical-practice-guideline-update-summary
#4
Kutluk Oktay, Brittany E Harvey, Alison W Loren
No abstract text is available yet for this article.
May 16, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29750579/harnessing-the-synergy-between-improvement-science-and-implementation-science-in-cancer-a-call-to-action
#5
Bogda Koczwara, Angela M Stover, Louise Davies, Melinda M Davis, Linda Fleisher, Shoba Ramanadhan, Florian R Schroeck, Leah L Zullig, David A Chambers, Enola Proctor
No abstract text is available yet for this article.
May 14, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29750578/so-you-want-to-be-a-principal-investigator
#6
Mansoor Saleh, Gurudatta Naik
Therapeutic trials represent the front line of clinical progress, where the rubber meets the road. The conduct of clinical trials requires unique skills, innate as well as learned, on the part of the investigators who conduct these studies. Often such skills are acquired on the job and are passed on from mentor to junior investigator. However, over the years, the role of the principal investigator (PI) has evolved into a vast list of roles and responsibilities that cannot readily be conveyed through a hands-on approach alone...
May 11, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29698125/in-response-to-care-provider-or-service-provider-what-should-the-role-of-radiation-oncologists-be-in-the-future
#7
George Dawson, Sonam Sharma, Kavita Dharmarajan
No abstract text is available yet for this article.
April 26, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29676949/supporting-the-future-of-the-oncology-workforce-asco-medical-student-and-trainee-initiatives
#8
Robert A Leon-Ferre, Daniel G Stover
No abstract text is available yet for this article.
April 20, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29676947/intravenous-chemotherapy-compounding-errors-in-a-follow-up-pan-canadian-observational-study
#9
Rachel E Gilbert, Melissa C Kozak, Roxanne B Dobish, Venetia C Bourrier, Paul M Koke, Vishal Kukreti, Heather A Logan, Anthony C Easty, Patricia L Trbovich
PURPOSE: Intravenous (IV) compounding safety has garnered recent attention as a result of high-profile incidents, awareness efforts from the safety community, and increasingly stringent practice standards. New research with more-sensitive error detection techniques continues to reinforce that error rates with manual IV compounding are unacceptably high. In 2014, our team published an observational study that described three types of previously unrecognized and potentially catastrophic latent chemotherapy preparation errors in Canadian oncology pharmacies that would otherwise be undetectable...
April 20, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29676946/unclassifiable-b-cell-lymphoma-with-symptomatic-hyperleukocytosis-managed-with-leukapheresis
#10
Lakshmi Manogna Chintalacheruvu, Jayadev Manikkam Umakanthan, Teddi Hernandez, Bryan Teruya, Apar Kishor Ganti
No abstract text is available yet for this article.
April 20, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29648923/impact-on-oncology-practices-of-including-drug-costs-in-bundled-payments
#11
Jeffery C Ward, Laura A Levit, Ray D Page, John E Hennessy, John V Cox, Deborah Y Kamin, Suanna S Bruinooge, Ya-Chen Tina Shih, Blase N Polite
INTRODUCTION: This analysis evaluates the impact of bundling drug costs into a hypothetic bundled payment. METHODS: An economic model was created for patient vignettes from: advanced-stage III colon cancer and metastatic non-small-cell lung cancer. First quarter 2016 Medicare reimbursement rates were used to calculate the average fee-for-service (FFS) reimbursement for these vignettes. The probabilistic risk faced by practices was captured by the type of patients seen in practices and randomly assigned in a Monte Carlo simulation on the basis of the given distribution of patient types within each cancer...
April 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29648922/reducing-wait-time-between-admission-and-chemotherapy-initiation
#12
Arjun Gupta, Jenny Li, Bernard Tawfik, Thao Pham, Sudarshan Pathak, Prabhjyot Singh, Esmaeil Porsa, Navid Sadeghi, Hsiao C Li
PURPOSE: Reducing the length of stay is a high-priority objective for all health care institutions. Delays in chemotherapy initiation for planned preadmissions lead to patient dissatisfaction and prolonged length of stay. PATIENTS AND METHODS: A multidisciplinary team was formed as part of the ASCO Quality Training Program. We aimed to reduce the time to initiation of chemotherapy from patient arrival at Parkland Hospital from a median of 6.2 hours at baseline to 4 hours over a 6-month period (35% reduction)...
April 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29648921/optimizing-anticancer-therapy-in-metastatic-non-castrate-prostate-cancer-asco-clinical-practice-guideline-summary
#13
Michael J Morris, R Bryan Rumble, Matthew I Milowsky
No abstract text is available yet for this article.
April 12, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29641273/monitoring-inbaskets-with-feedback-to-providers-enhances-the-timeliness-of-patient-care
#14
Amelia A Trant, Michael Strait, Rory Kaplan, Vanna Dest, Adam Roshka, Catherine A Lyons, Kevin A Vest, Tessa Steffen, Anne Chiang, Kerin B Adelson
PURPOSE: Electronic health records have changed providers' workflow. Epic's InBasket supplants traditional communication and is a central hub for clinical information. Failure to promptly complete records impairs communication and revenue collection. By tracking providers' InBasket activities and offering feedback, we hoped to improve InBasket management and interdisciplinary communication. METHODS: We created a report to track 273 providers' InBasket activities, including ambulatory transcriptions, chart cosignatures, order cosignatures, patient calls, results, and billable encounters...
April 11, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29641272/impact-of-a-statewide-oral-oncolytic-initiative-on-five-participating-practices
#15
Emily Mackler, Gianni B Scappaticci, Teresa M Salgado, Laura Petersen, Emily J Davis, Emily Peltier, Jennifer J Griggs, Roy T Sabo, Karen B Farris
PURPOSE: The shift from infusion to oral oncolytic therapy presents challenges to oncology practitioners. The purpose of this study was to describe how a statewide quality-improvement collaborative can enhance quality of care for patients receiving oral oncolytic therapy. METHODS: The Michigan Oncology Quality Consortium hosted a series of learning sessions focused on oral oncolytic quality improvement, providing multiple resources to oncology community practices...
April 11, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29601250/examining-trends-in-cost-and-clinical-benefit-of-novel-anticancer-drugs-over-time
#16
Ronak Saluja, Vanessa S Arciero, Sierra Cheng, Erica McDonald, William W L Wong, Matthew C Cheung, Kelvin K W Chan
PURPOSE: The purpose of this study was to determine if clinical benefits of novel anticancer drugs, measured by the ASCO Value Framework and European Society of Medical Oncology (ESMO) Magnitude of Clinical Benefit Scale, have increased over time in parallel with increasing costs. METHODS: Anticancer drugs from phase III randomized controlled trials cited for clinical efficacy evidence in drug approvals between January 2006 to December 2015 were identified and scored using both frameworks...
March 30, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29589987/molecular-testing-guideline-for-the-selection-of-lung-cancer-patients-for-treatment-with-targeted-tyrosine-kinase-inhibitors-american-society-of-clinical-oncology-endorsement-summary-of-the-college-of-american-pathologists-international-association-for-the
#17
https://www.readbyqxmd.com/read/29589986/burning-mouth-pain-a-case-report
#18
Ritika Oberoi-Jassal, Diane Portman, Joshua Smith, Sahana Rajasekhara, Vijay V Desai, Kristine A Donovan, Young D Chang
No abstract text is available yet for this article.
March 28, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29558252/ibrutinib-for-the-management-of-schnitzler-syndrome-a-novel-therapy-for-a-rare-condition
#19
Prachi Jani, Megan B Vissing, Salman Ahmed, Jason C Sluzevich, Sonikpreet Aulakh, Victoria Alegria, Meghna Ailawadhi, Asher Chanan-Khan, Sikander Ailawadhi
No abstract text is available yet for this article.
March 20, 2018: Journal of Oncology Practice
https://www.readbyqxmd.com/read/29558251/impact-of-socioeconomic-status-on-pretreatment-weight-loss-and-survival-in-non-small-cell-lung-cancer
#20
Steven K M Lau, Bhavani S Gannavarapu, Kristen Carter, Ang Gao, Chul Ahn, Jeffrey J Meyer, David J Sher, Aminah Jatoi, Rodney Infante, Puneeth Iyengar
PURPOSE: Socioeconomic status (SES) influences health care outcomes, but the influence of primary payer on cancer-associated wasting is unknown. We hypothesized that primary payer as an indicator of SES would influence pretreatment cancer-associated weight loss and treatment outcomes. MATERIALS AND METHODS: Retrospective review of medical records identified 1,366 patients with non-small-cell lung cancer (NSCLC) consecutively treated at a tertiary care health system between January 1, 2006 and December 31, 2013...
April 2018: Journal of Oncology Practice
journal
journal
41216
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"